Bio

Russell Franklin counsels private and publicly held companies in connection with complex strategic transactions, including structuring and negotiating mergers and acquisitions (M&A), minority investments, and joint venture transactions for strategic and financial clients. His practice also includes general stock and asset transactions, and purchases and sales resulting from bankruptcy and out-of-court restructurings. Russell routinely partners with life sciences transactions (LST) lawyers on life sciences M&A and matters that include one or more equity components. Russell is a member of the firm’s SPAC Task Force and has counseled clients contemplating SPAC and de-SPAC transactions. By focusing on understanding what clients are looking to achieve, and leveraging his experience, Russell strives to provide creative solutions that allow clients to meet their business objectives. In some instances, this amounts to Russell providing advice to clients throughout the entire lifecycle of a target including acquiring the asset, managing the asset, and, where applicable, ultimately disposing of the asset. Russell counsels clients across numerous industries including healthcare, life sciences, retail, financial services, and media.